[BREAKING] [Exclusive] ABL Bio Passes Phase 2 Clinical Trials for ＂'s NTU One Q ＂, a rare disease (N2DY3) treatment

31 January Share

[BREAKING] [Exclusive] ABL Bio Passes Phase 2 Clinical Trials for ＂'s NTU One Q ＂, a rare disease (N2DY3) treatment

【単独】 ABLバイオ、希少疾患(N2DY3)治療剤 ＂ エヌツーワンキュー＂ 臨床2相通過

[单独]ABL BIO, 罕见疾病(N2DY3) 治疗剂 ＂ N2O 1Q ＂ 通过临床2期

[Монолог] AVIEL Bio, лекарства для лечения редких заболеваний (N2DY3) прошли клиническую 2-ю стадию.

[단독] 에이비엘바이오, 희귀질환(N2DY3) 치료제 '엔투원큐' 임상 2상 통과 [More News]